John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 19,000 shares at $24.58 ($463K) on 2015-10-07, disclosed to the SEC on 2015-10-09.
Scheduled sale ($463k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.01 | 6,548 | $157K | 33.9% |
| 2 | $24.58 | 12,452 | $306K | 66.1% |
| Total | $24.38 avg | 19,000 | $463K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |
| XLRN | SELL | 2015-08-12 | $542K | — | Filing → |